Free Trial

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) Trading 0.8% Higher - Should You Buy?

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation logo with Computer and Technology background

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT - Get Free Report) shares were up 0.8% during trading on Thursday . The company traded as high as GBX 1,475.60 ($20.14) and last traded at GBX 1,475.60 ($20.14). Approximately 442 shares were traded during mid-day trading, a decline of 94% from the average daily volume of 7,888 shares. The stock had previously closed at GBX 1,463.60 ($19.98).

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Trading Up 0.8%

The firm has a market cap of £605.31 million and a price-to-earnings ratio of -1,341.45. The company has a 50 day moving average of GBX 1,468.49 and a 200 day moving average of GBX 1,576.62.

About First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation

(Get Free Report)

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Right Now?

Before you consider First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation wasn't on the list.

While First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines